Normal tissue tolerance to external beam radiation therapy: Lung;Dose de tolérance à l'irradiation des tissus sains: le poumon

Cancer/Radiotherapie

Volumn 14, Issue 4-5, 2010, Pages 312-318

  Ortholan, C ^a   Mornex, F ^b,c  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Lung; Radiation pneumonitis; Radiotherapy; Toxicity

Indexed keywords

CLINICAL FEATURE; COUGHING; DOSIMETRY; DYSPNEA; EXTERNAL BEAM RADIOTHERAPY; LUNG DISEASE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SHORT SURVEY; TUMOR LOCALIZATION;

AGE FACTORS; HUMANS; LUNG; MULTICENTER STUDIES AS TOPIC; PROBABILITY; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIATION TOLERANCE; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 77955335143     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.02.009     Document Type: Short Survey

References (42)

1. Bradley J., Graham M.V., Winter K., Purdy J.A., Komaki R., Roa W.H., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005, 61:318-328.
2. Bradley J.D., Hope A., El Naqa I., Apte A., Lindsay P.E., Bosch W., et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007, 69:985-992.
3. Chen S., Zhou S., Zhang J., Yin F.F., Marks L.B., Das S.K. A neural network model to predict lung radiation induced pneumonitis. Med Phys 2007, 34:3420-3427.
4. Choi N.C., Kanarek D.J. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 1994, 10:S219-S230.
5. Claude L., Pérol D., Ginestet C., Falchero L., Arpin D., Vincent M., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 2004, 71:175-181.
6. Fu X.L., Huang H., Bentel G., Clough R., Jirtle R.L., Kong F.M., et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 2001, 50:899-908.
7. Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323-329.
8. Hernando M.L., Marks L.B., Bentel G.C., Zhou S.M., Hollis D., Das S.K., et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001, 51:650-659.
9. Hope A.J., Lindsay P.E., El Naqa I., Alaly J.R., Vicic M., Bradley J.D., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 2006, 65:112-124.
10. Radonc.duke.edu [site internet de Duke University School of Medicine Department of Radiation Oncology]. Durham, NC: Duke University Health System © 2010. A neural network model for predicting radiotherapy (RT) induced lung injury. Disponible sur (accès le 24 mars 2010). http://www.radonc.duke.edu/modules/div_medphys/index.php?id=24.
11. Hurkmans C.W., Cho B.C., Damen E., Zijp L., Mijnheer B.J. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 2002, 62:163-171.
12. Inoue A., Kunitoh H., Sekine I., Sumi M., Tokuuye K., Saijo N. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 2001, 49:649-655.
13. Kwa S.L., Lebesque J.V., Theuws J.C., Marks L.B., Munley M.T., Bentel G., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998, 42:1-9.
14. Lee J.S., Scott C., Komaki R., Fossella F.V., Dundas G.S., McDonald S., et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 1996, 14:1055-1064.
15. Lind P.A., Marks L.B., Hollis D., Fan M., Zhou S.M., Munley M.T., et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 2002, 54:340-347.
16. Lind P.A., Wennberg B., Gagliardi G., Rosfors S., Blom-Goldman U., Lideståhl A., et al. ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys 2006, 64:765-770.
17. Marks L.B., Munley M.T., Bentel G.C., Zhou S.M., Hollis D., Scarfone C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 1997, 39:563-570.
18. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005, 63(1):5-24.
19. Monson J.M., Stark P., Reilly J.J., Sugarbaker D.J., Strauss G.M., Swanson S.J., et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998, 82:842-850.
20. Muren L.P., Maurstad G., Hafslund R., Anker G., Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 2002, 62:173-183.
21. Oetzel D., Schraube P., Hensley F., Sroka-Pérez G., Menke M., Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995, 33:455-460.
22. Piotrowski T., Matecka-Nowak M., Milecki P. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Neoplasma 2005, 52:56-62.
23. Ohe Y. Treatment-related death from chemotherapy and thoracic radiotherapy for advanced cancer. Panminerva Med 2002, 44:205-212.
24. Rancati T., Ceresoli G.L., Gagliardi G., Schipani S., Cattaneo G.M. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003, 67:275-283.
25. Recht A., Ancukiewicz M., Alm El-Din M.A., Lu X.Q., Martin C., Berman S.M., et al. Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy. J Clin Oncol 2009, 27(24):3887-3893.
26. Roach M.3rd, Gandara D.R., Yuo H.S., Swift P.S., Kroll S., Shrieve D.C., et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 1995, 13:2606-2612.
27. Robnett T.J., Machtay M., Vines E.F., McKenna M.G., Algazy K.M., McKenna W.G. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000, 48:89-94.
28. Rodrigues G., Lock M., D'Souza D., Yu E., Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer--a systematic review. Radiother Oncol 2004, 71:127-138.
29. Sampath S., Schultheiss T.E., Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys 2005, 63:876-884.
30. Schaake-Koning C., van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992, 326:524-530.
31. Schild S.E., Stella P.J., Geyer S.M., Bonner J.A., McGinnis W.L., Mailliard J.A., et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003, 21:3201-3206.
32. Seppenwoolde Y., Lebesque J.V., de Jaeger K., Belderbos J.S., Boersma L.J., Schilstra C., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003, 55:724-735.
33. Guide des procédures de radiothérapie externe 2007. Cancer Radiother 2008, 12:143-313. Société française de radiothérapie oncologique.
34. Tsougos I., Nilsson P., Theodorou K., Kjellén E., Ewers S.B., Jarlman O., et al. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy. Phys Med Biol 2007, 52:1055-1073.
35. Tsoutsou P.G., Koukourakis M.I. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 2006, 66:1281-1293.
36. Tsujino K., Hirota S., Endo M., Obayashi K., Kotani Y., Satouchi M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003, 55:110-115.
37. Tsujino K., Hirota S., Kotani Y., Kado T., Yoden E., Fujii O., et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys 2006, 64:1100-1105.
38. Wang J.Y., Chen K.Y., Wang J.T., Chen J.H., Lin J.W., Wang H.C., et al. Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002, 54:735-741.
39. Willner J., Jost A., Baier K., Flentje M. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 2003, 179:548-556.
40. Yamada M., Kudoh S., Hirata K., Nakajima T., Yoshikawa J. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 1998, 34:71-75.
41. Yorke E.D., Jackson A., Rosenzweig K.E., Merrick S.A., Gabrys D., Venkatraman E.S., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002, 54:329-339.
42. Yu T.K., Whitman G.J., Thames H.D., Buzdar A.U., Strom E.A., Perkins G.H., et al. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst 2004, 96:1676-1678.